Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF- binding protein-3 in liver cirrhois

Journal of Hepatology

Volumn 27, Issue 5, 1997, Pages 796-802

  Assy, Nimer ^a,b   Hochberg, Zeev ^a   Amit, Tamar ^a   Shen Orr, Zila ^a   Enat, Rafael ^a,b   Baruch, Yaacov ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cirrhosis; Growth hormone; Growth hormone binding protein; Insulin like growth factor I; Insulin like growth factor binding protein 3

Indexed keywords

ARTICLE; DISEASE SEVERITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALNUTRITION; NUTRITIONAL HEALTH; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; VIRUS INFECTION;

EID: 0030668238     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80315-7     Document Type: Article

References (38)

1. Zanoboni A, Zanoboni-Muciaccia W. Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis. J Clin Endocrinol Metab. 45:1977;576-578.
2. Muggeo M, Tiengo A, Fedele D, Crepaldi G. Altered control of growth hormone secretion in patients with cirrhosis of the liver. Arch Intern Med. 139:1979;1157-1160.
3. Moller S, Becker U. Insulin-like growth factor 1 and growth hormone in chronic liver disease. Dig Dis. 10:1992;239-248.
4. Wu A, Grant DB, Hambley J, Levi AJ. Reduced serum somatomedin activity in patients with chronic liver disease. Clin Sci Mol Med. 47:1974;359-366.
5. Sheppard MS, Minuk GY, Bhaumick B, Bala RM. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II. Clin Invest Med. 10:1987;49-53.
6. Baruch Y, Amit T, Hertz P, Enat R, Youdim MBH, Hochberg Z. Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab. 73:1991;777-780.
7. Caufriez A, Reding P, Urbain D, Golstein J, Copinschi G. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest. 14:1991;317-321.
8. Hattori N, Kurahachi H, Ikekubo K, Ishihara T, Moridera K, Hino M, et al. Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with live cirrhosis. Metabolism. 41:1992;377-381.
9. Ghahary A, Minuk GY, Luo J, Gauthier T, Murphy LJ. Effect of partial hepatectomy on hepatic insulinlike growth factor binding protein-1 expression. Hepatology. 15:1992;1125-1131.
10. LeRoith D, Werner H, Burguera B, Roberts CT Jr, Mulroney S, Haramati A. The insulin-like growth factor family of peptides, binding proteins and receptors: their potential role in tissue regeneration. Adv Exp Med Biol. 321:1992;21-28.
11. LeRoith D, Werner H, Burguera B, Roberts CT Jr, Mulroney S, Haramati A. The insulin-like growth factor family of peptides, binding proteins and receptors: their potential role in tissue regeneration. Adv Exp Med Biol. 321:1992;29-30. discussion.
12. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology. 21:1995;680-688.
13. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab. 80:1995;1148-1157.
14. Isaksson OGP, Edén S, Jansson J-O. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 47:1985;483-499.
15. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:1987;537-543.
16. Tygstrup N. Determination of the hepatic elimination capacity of galactose by single injection. Scand J Clin Lab Invest Suppl. 18:1966;118-125.
17. Bircher J. Assessment of prognosis in advanced liver disease: to score or to measure, that's the question. Hepatology. 6:1986;1036-1037.
18. Child CG. The Liver and Portal Hypertension. 1964;W.B. Saunders, Philadelphia.
19. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
20. Maggi U, Rossi G, Colledan M, Fassati LR, Gridelli B, Reggiani P, et al. Child-Pugh score and liver transplantation. Transplant Proc. 25:1993;1769-1770.
21. Rudman D, Kutner MH, Blackstone RD, Jansen RD, Patterson JH. Normal variant short stature: subclassification based on responses to exogenous human growth hormone. J Clin Endocrinol Metab. 49:1979;92-99.
22. Bistrian BR, Blackburn GL, Sherman M, Scrimshaw NS. Therapeutic index of nutritional depletion in hospitalized patients. Surg Gynecol Obstet. 141:1975;512-516.
23. Amit T, Barkey RJ, Youdim MBH, Hochberg Z. A new and convenient assay of growth hormone-binding protein activity in human serum. J Clin Endocrinol Metab. 71:1990;474-480.
24. Møller S, Becker U, Gronbæk M, Juul A, Winkler K, Skakkebæk NE. Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis. J Hepatol. 21:1994;710-717.
25. Chang T-C, Lin J-J, Yu S-C, Chang T-J. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology. 11:1990;123-126.
26. Hochberg Z, Phillip M, Youdim MBH, Amit T. Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatility. Metabolism. 42:1993;1617-1623.
27. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab. 71:1990;797-805.
28. Cuneo RC, Hickman PE, Wallace JD, Teh BT, Ward G, Veldhuis JD, et al. Altered endogenous growth hormone secretary kinetics and diurnal GH-binding profiles in adults with chronic liver disease. Clin Endocrinol. 43:1995;265-275.
29. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 76:1993;1610-1616.
30. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJP, Hill DJ. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab. 79:1994;1871-1876.
31. Scharf J-G, Schmidt-Sandte W, Pahernik SA, Koebe HG, Hartmann H. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit of the insulin-like growth factor ternary binding protein complex in primary cultures of human hepatocytes. J Hepatol. 23:1995;424-430.
32. Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: an analytical review. Hepatology. 19:1994;518-533.
33. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 15:1994;80-101.
34. Baxter RC, Bryson JM, Turtle JR. The effect of fasting on liver receptors for prolactin and growth hormone. Metabolism. 30:1981;1086-1090.
35. Clemmons DR, Underwood LE, Dickerson Rn, Brown RO, Hak LJ, MacPhee RD, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurement to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr. 41:1985;191-198.
36. Clemmons DR, Underwood LE. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr. 11:1991;393-412.
37. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MBH, et al. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism. 41:1992;106-112.
38. Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS. Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med. 78:1985;228-234.